Developing Drosophila melanogaster Models for Imaging and Optogenetic Control of Cardiac Function.


Journal

Journal of visualized experiments : JoVE
ISSN: 1940-087X
Titre abrégé: J Vis Exp
Pays: United States
ID NLM: 101313252

Informations de publication

Date de publication:
25 08 2022
Historique:
entrez: 12 9 2022
pubmed: 13 9 2022
medline: 15 9 2022
Statut: epublish

Résumé

Using Drosophila melanogaster (fruit fly) as a model organism has ensured significant progress in many areas of biological science, from cellular organization and genomic investigations to behavioral studies. Due to the accumulated scientific knowledge, in recent years, Drosophila was brought to the field of modeling human diseases, including heart disorders. The presented work describes the experimental system for monitoring and manipulating the heart function in the context of a whole live organism using red light (617 nm) and without invasive procedures. Control over the heart was achieved using optogenetic tools. Optogenetics combines the expression of light-sensitive transgenic opsins and their optical activation to regulate the biological tissue of interest. In this work, a custom integrated optical coherence tomography (OCT) imaging and optogenetic stimulation system was used to visualize and modulate the functioning D. melanogaster heart at the 3rd instar larval and early pupal developmental stages. The UAS/GAL4 dual genetic system was employed to express halorhodopsin (eNpHR2.0) and red-shifted channelrhodopsin (ReaChR), specifically in the fly heart. Details on preparing D. melanogaster for live OCT imaging and optogenetic pacing are provided. A lab-developed integration software processed the imaging data to create visual presentations and quantitative characteristics of Drosophila heart function. The results demonstrate the feasibility of initiating cardiac arrest and bradycardia caused by eNpHR2.0 activation and performing heart pacing upon ReaChR activation.

Identifiants

pubmed: 36094265
doi: 10.3791/63939
pmc: PMC9825051
mid: NIHMS1850699
doi:

Types de publication

Journal Article Video-Audio Media Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIBIB NIH HHS
ID : R01 EB025209
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL156265
Pays : United States

Références

Physiol Rep. 2016 Feb;4(3):
pubmed: 26834237
J Vis Exp. 2009 Nov 16;(33):
pubmed: 19918216
Nat Neurosci. 2015 Sep;18(9):1213-25
pubmed: 26308982
Nat Methods. 2011 Jan;8(1):26-9
pubmed: 21191368
Circulation. 2019 Mar 5;139(10):e56-e528
pubmed: 30700139
Science. 2010 Nov 12;330(6006):971-4
pubmed: 21071670
PLoS Genet. 2010 May 27;6(5):e1000969
pubmed: 20523889
Circulation. 2006 Jul 11;114(2):e35-6
pubmed: 16831991
Sci Adv. 2015 Oct 09;1(9):e1500639
pubmed: 26601299
Nat Methods. 2010 Nov;7(11):897-900
pubmed: 20881965
Sci Transl Med. 2019 Feb 27;11(481):
pubmed: 30814339
J Cardiovasc Dev Dis. 2016 Apr 12;3(2):
pubmed: 29367564
Hum Mol Genet. 2013 Sep 15;22(18):3798-806
pubmed: 23696452
Nat Rev Cardiol. 2021 May;18(5):349-367
pubmed: 33340010
Science. 2009 May 22;324(5930):1080-4
pubmed: 19389999
Sci Transl Med. 2012 Nov 21;4(161):161ra152
pubmed: 23147003
Dis Model Mech. 2011 May;4(3):411-20
pubmed: 21183476
Biomed Opt Express. 2020 Feb 21;11(3):1568-1579
pubmed: 32206429
Gene. 2004 Nov 10;342(1):1-11
pubmed: 15527959
J Comp Physiol B. 2016 Oct;186(7):829-41
pubmed: 27209390
Nat Neurosci. 2005 Sep;8(9):1263-8
pubmed: 16116447
Methods. 2014 Jun 15;68(1):265-72
pubmed: 24727147
Methods Protoc. 2019 Aug 22;2(3):
pubmed: 31443492
Circ Res. 2011 Sep 16;109(7):794-806
pubmed: 21921272
Dis Model Mech. 2016 Mar;9(3):235-44
pubmed: 26935102
Commun Biol. 2020 Jun 29;3(1):336
pubmed: 32601302
Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1394-9
pubmed: 16432241
J Vis Exp. 2016 Dec 12;(118):
pubmed: 28060288
J Comp Physiol A Neuroethol Sens Neural Behav Physiol. 2017 Oct;203(10):791-806
pubmed: 28612236
Curr Alzheimer Res. 2011 May;8(3):313-22
pubmed: 21524270
Nat Biotechnol. 2015 Jul;33(7):750-4
pubmed: 26098449

Auteurs

Elena Gracheva (E)

Department of Biomedical Engineering, Washington University in St. Louis.

Fei Wang (F)

Department of Biomedical Engineering, Washington University in St. Louis.

Abigail Matt (A)

Department of Biomedical Engineering, Washington University in St. Louis.

Hongwu Liang (H)

Department of Biomedical Engineering, Washington University in St. Louis.

Matthew Fishman (M)

Department of Biomedical Engineering, Washington University in St. Louis; Department of Computer Science and Engineering, Washington University in St. Louis.

Chao Zhou (C)

Department of Biomedical Engineering, Washington University in St. Louis; chaozhou@wustl.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH